Fundraising FoxTychon Biosciences
Minneapolis, US · Founded 2014 · Delaware LLC
Find your way into Tychon Biosciences
Sign up to see every warm intro you have to Tychon Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tychon Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DJ
Danny J. CunaginCo-Founder, CEO & Board MemberDanny Cunagin is a co-founder and former CEO of Tychon, an immunotherapy company. He has extensive experience in biotech and medtech, including prior roles as co-founder and co-CEO of Invenshure (a biotech holding company), CEO of MEKanistic Therapeutics, co-founder and former CEO of Imbio (sold to 4DMedical), and leader of Steady State Imaging (sold to GE Healthcare); he holds a background in mechanical and biomedical engineering.
MS
Mark SylvesterExecutive
TD
Troy D. KopischkeCo-Founder / Board MemberTroy Kopischke is an executive officer and director at Tychon Biosciences. He has experience in technology evaluation, market assessment, business development, and operational execution across companies operating in the US, Europe, and Asia.
Reported raises · per SEC filings
Form D private placements$670.7K disclosed across 2 rounds · 2015–2018
▶$200KraisedOct 2018 · 2 investors · Other TechnologyRule 506(b)
▶$200KraisedOct 2018 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles Muscoplat, PhDExecutive Officer
- Danny J. CunaginExecutive Officer, Director
- Mark SylvesterExecutive Officer
- Arek Z. Dudek, MD PhDExecutive Officer
- John MacDonald, PhDExecutive Officer
- Troy D. KopischkeExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $200K
- Minimum investment
- $50K
- First sale
- Oct 2018
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$470.7KraisedNov 2015 · 7 investors · Other TechnologyRule 506(b)
▶$470.7KraisedNov 2015 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Danny J. CunaginExecutive Officer, Director
- Mark SylvesterExecutive Officer
- Troy D. KopischkeExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $470.7K
- First sale
- Nov 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Tychon Biosciences went on to found or lead other companies.
Frequently asked questions
- How much funding has Tychon Biosciences raised?
- Tychon Biosciences has disclosed $670.7K raised across 2 rounds.
- Where is Tychon Biosciences headquartered?
- Tychon Biosciences is headquartered in Minneapolis, US.